POWER 3 MEDICAL PRODUCTS (OTC BB: PWRM.OB)
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers. With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents. Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops.
Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced today that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."
"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."
"We are within striking distance of realizing an Alzheimer's clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions," added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
Quanta Services, Inc. (NYSE:PWR) decreased 2.16% to close at $19.52. PWR traded 1.07 million shares for the day and its earning per share remained $0.79. Quanta Services, Inc. (Quanta) is a provider of specialty contracting services, offering infrastructure solutions to the electric power, natural gas, oil and telecommunications industries. The services it provides include the design, installation, upgrade, repair and maintenance of infrastructure within each of the industries it serves, such as electric power transmission and distribution networks and substation facilities, natural gas and oil transmission and distribution systems, and fiber optic, copper and coaxial cable networks used for video, data and voice transmission.
Lennar Corporation (NYSE:LEN) decreased 1.48% to close at $14.68. LEN traded 4.02 million shares for the day and its earning per share remained $0.53. Lennar Corporation is a homebuilder and a provider of financial services. The home building operations include the construction and sale of single-family attached and detached homes, multi-level residential buildings, as well as the purchase and sale of residential land directly, and through unconsolidated entities in which the Company have investments. The Company’s homebuilding activities operate in four business segments: Homebuilding East, Homebuilding Central, Homebuilding West and Homebuilding Houston.
KB Home (NYSE:KBH) increased 0.19% to close at $10.71. KBH traded 1.49 million shares for the day and its earning per share remained $0.18. KB Home operates a homebuilding and financial services business serving homebuyers in markets nationwide. It constructs and sells homes through its operating divisions across the United States under the name KB Home. The Company operates in 10 states and 30 markets, including California, Arizona, Nevada, Colorado, Texas, Florida, Maryland, North Carolina, South Carolina and Virginia.
Crown Equity Holdings Inc. (OTC BB: CRWE.OB)
Crown Equity Holdings Inc. knows that bigger is better. That’s why the company is expanding its business by opening a second office in Pakistan. With its mission to increase its offerings of up-to-date news and world affairs from the Mideast, Far East and Europe, the company will add an additional workforce of 25 associates to the CRWE Newswire team. The new venue will be located in the city of Attock and will be managed by Zeeshan Shabbir, who also runs the office in Islamabad, Pakistan. CRWE’s proprietary network technology allows its publishing department to get its content to millions of readers daily across the world.
Crown Equity Holdings‘ CRWE Newswire is growing with the flow.The company has announced that it is expanding its business by opening another office in Pakistan. The new venue will be located in the city of Attock and, like its sister office in Islamabad, will be managed by Zeeshan Shabbir. In the process of adding an additional workforce of 25 associates to the CRWE Newswire team, the new office will increase the company’s offerings of up-to-date news and world affairs from the Mideast, Far East, and Europe via its online newswires.
Crown Equity Holdings, Inc. has increased its workforce to an amount of 35, compared to this time last year’s head count of 6, which is a 580% personnel increase . This is in addition to the 10 contractors we recently hired in Pakistan.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).